secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001193125-22-165676
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Anthem reaffirms FY 2022 adjusted net income >$28.40/share
----------------------------------------------------------

- Full-year 2022 net income guidance >$26.43 per share, including ~$1.97/share net unfavorable items.
- Excluding unfavorable items, adjusted net income expected >$28.40 per share.
- Guidance excludes adjustments beyond those reported in Q1 2022 earnings release.
- Officers will speak with investors over the next several weeks, reaffirming this outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312522165676/0001193125-22-165676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312522165676/d358893d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-165676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer